These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20958930)

  • 21. Development of a novel equine influenza virus live-attenuated vaccine.
    Rodriguez L; Reedy S; Nogales A; Murcia PR; Chambers TM; Martinez-Sobrido L
    Virology; 2018 Mar; 516():76-85. PubMed ID: 29331866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses.
    Morley PS; Hanson LK; Bogdan JR; Townsend HG; Appleton JA; Haines DM
    Vet Microbiol; 1995 Jun; 45(1):81-92. PubMed ID: 7653031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study.
    Daly JM; Sindle T; Tearle J; Barquero N; Newton JR; Corning S
    Equine Vet J; 2007 Sep; 39(5):446-50. PubMed ID: 17910270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus.
    Mumford JA; Wood JM; Folkers C; Schild GC
    Epidemiol Infect; 1988 Jun; 100(3):501-10. PubMed ID: 2837409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.
    Fougerolle S; Legrand L; Garrett D; Birand I; Foursin M; D'Ablon X; Bayssat P; Newton RJ; Pronost S; Paillot R
    Vaccine; 2016 Jul; 34(33):3787-95. PubMed ID: 27269055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine.
    Lopez AM; Hecker R; Mutwiri G; van Drunen Littel-van den Hurk S; Babiuk LA; Townsend HG
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):103-10. PubMed ID: 16950519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge.
    Pouwels HG; Van de Zande SM; Horspool LJ; Hoeijmakers MJ
    Vet Rec; 2014 Jun; 174(25):633. PubMed ID: 24795071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
    Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
    J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Little evidence of human infection with equine influenza during the 2007 epizootic, Queensland, Australia.
    Burnell FJ; Holmes MA; Roiko AH; Lowe JB; Heil GL; White SK; Gray GC
    J Clin Virol; 2014 Feb; 59(2):100-3. PubMed ID: 24360918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of respiratory viruses in equines in Brazil.
    Mancini DA; Pereira AS; Mendonça RM; Kawamoto AH; Alves RC; Pinto JR; Mori E; Richtzenhain LJ; Mancini-Filho J
    Rev Inst Med Trop Sao Paulo; 2014; 56(3):191-5. PubMed ID: 24878995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective efficacy of inactivated equine influenza (H3N8) virus vaccine in murine model.
    Pavulraj S; Virmani N; Bera BC; Joshi A; Anand T; Virmani M; Singh R; Singh RK; Tripathi BN
    Vet Microbiol; 2017 Oct; 210():188-196. PubMed ID: 29103691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013.
    Kim EJ; Kim BH; Yang S; Choi EJ; Shin YJ; Song JY; Shin YK
    J Vet Med Sci; 2015 Nov; 77(11):1517-21. PubMed ID: 26062436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with EIV A/eq2/Richmond/1/07.
    Paillot R; Prowse L; Montesso F; Stewart B; Jordon L; Newton JR; Gilkerson JR
    Vet Microbiol; 2013 Sep; 166(1-2):22-34. PubMed ID: 23769636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of equine influenza virus H3Nx Florida clade 2 in Arabian racehorses in Egypt.
    Ahmed BM; Bayoumi MM; Farrag MA; Elgamal MA; Daly JM; Amer HM
    Virol J; 2022 Nov; 19(1):185. PubMed ID: 36371185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity.
    Garrett D; Montesso F; Fougerolle S; Lopez-Alvarez MR; Birand I; De Bock M; Huang CM; Legrand L; Pronost S; Paillot R
    Vet Microbiol; 2017 Nov; 211():150-159. PubMed ID: 29102112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of equine influenza A (H3N8) activity in horses from Eastern and Central Saudi Arabia: 2013-2015.
    Hemida MG; Perera RAPM; Chu DKW; Alnaeem AA; Peiris M
    Equine Vet J; 2019 Mar; 51(2):218-221. PubMed ID: 30074632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Equine Influenza Virus Status in the Republic of Korea from 2020 to 2022.
    Lim SI; Kim MJ; Kim MJ; Lee SK; Yang HS; Kwon M; Lim EH; Ouh IO; Kim EJ; Hyun BH; Lee YH
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.